Sunday 6 December 2015

Shilchar Technologies CMP 192.10

Facts:

  1. Consistently increasing topline for last 5 years and bottomline for last 3 years.
  2. Decent operating margins
  3. Positive cash flow from operations since FY 12
  4. For H1 FY 16, Topline of Rs 52.80 Cr, Net Profit - Rs 4.38 Cr, EPS - Rs 11.49. For full year FY 15, topline was Rs 105.87 Cr, Net profit - Rs5.81 Crs and EPS - 15.24
  5. Low Equity of Rs 3.81 Crs
  6. Dividend Paying. Dividend payout increased from Rs 0.50 in FY 13 to Rs 1.50 in FY 15.
  7. Nil Long Term Debt
  8. Promoter Holding - 65.85%, More than 1% holders - 28.00%. Remaining Free float - 6.15%

Screenshots supporting above are attached below:





Saturday 28 November 2015

Elnet Technologies CMP 82.45












Facts
  • Consistent Operating and PAT Margin.
  • Low Equity Base of Rs 4 Crs thereby high eps.
  • H1 FY 16 - Net Profit of Rs 3.46 Crs 
  • Current Market Cap ~ Rs 33 Crs
  • Consistent positive cash flow from operations
  • Nil Bank borrowing....only unsecured loans of Rs 4.26 Crs from promoter / director

Friday 13 November 2015

Panchsheel Organics recommended at Rs 31.35 on 11 Sep 2014 is today locked in upper circuit at 94.55.

Panchsheel Organics recommended at 31.35 on 11 Sep 2014 is today locked in upper circuit at 94.55...Cheers...a 3 bagger.

B2B Software CMP 9.72 - BSE Code 531268

Management Discussion and Analysis from AR

http://www.bseindia.com/bseplus/AnnualReport/531268/5312680315.pdf

B2B - Health Care Division
The Healthcare Information Technology industry continued to evolve in 2014 with new coding standards coming to the forefront. Perhaps the most noteworthy change is the transition to ICD-10, a far more comprehensive coding standard than its predecessor, ICD-9. In addition, GeniusDoc has made strides to expand on its electronic prescribing functionality by including the ability to prescribe controlled substances (EPCS) as well as send clinical messages. The initial flurry of Meaningful Use incentives is drawing to a close, thus putting many physicians at a crossroads. Either tolerate their EHR for the foreseeable future or undertake the painful process of finding and implementing a new EHR throughout their practice. Fortunately, GeniusDoc has been able to reap the benefits of its favorable reputation in the medical community as several practices have moved on from less desirable EHRs to GeniusDoc based largely on word of mouth. Consequently, this transition has helped GeniusDoc expand its reach into previously untapped regions like the Pacific Northwest (i.e. Washington) and the Southeast (i.e Alabama). The last few years have also featured a wave of hospitals buying out private practices as well as consolidation. The movement towards hospital settings has not fazed GeniusDoc as practices have gone to great lengths to ensure that they are still able to use the application despite the change in ownership. The increase in consolidation has allowed the company to leverage its existing customer base as physicians and practices are joining GeniusDoc affiliated practices. One of the hallmarks of GeniusDoc is its commitment to constantly improving the product both internally through customer feedback and externally by integrating third parties into the application. Beyond servicing the expected medical needs of practices, GeniusDoc has matured into an incredibly robust practice management application capable of accommodating multiple workflows. In fact, many practices have incorporated the GeniusDoc Patient Portal into their workflow to reduce the burden on front office staff as well as improve transparency with patients. Moreover, several practices have leveraged the tools inside of GeniusDoc to streamline patient visits (i.e. Dashboard, Synopsis, etc.) by tapping into a horde of readily available information. GeniusDoc collaborated with notable credit card processor, TransFirst, to develop an integrated solution that streamlines payment workflow in front offices. Along those lines, GeniusDoc also worked with an appointment reminder service, Callpointe, to relieve the burden placed on front offices to constantly reach out to patients to confirm patient appointments. In short, the future continues to look bright for GeniusDoc as the product continues to mature and evolve while the customer base grows. 

B2B in the Microsoft Dynamics world B2B is India's leading provider of business consulting services delivering exceptional service and sustainable value through consulting, software and IT implementation in Microsoft Dynamics World. Our diverse clientele includes mid-sized companies and larger enterprises. As a Microsoft partner – B2B advances and adds value to Microsoft's leading business solutions and client relationships by ensuring that companies get the highest level of attention, expertise and results from Microsoft technology. With more than 180+ client engagements, B2B leverages its deep expertise in Microsoft Dynamics and Microsoft technology to deliver a competitive edge to organizations worldwide. B2B LIFT is certified by Third Party Consulting Company for GMP. Our Reseller base is consistently increasing with more than 150 add-on sales in India and Abroad. Our Reseller base abroad spreads across, Singapore, Philippines, Malaysia, Vietnam, Sri Lanka, Australia, South Africa, UAE, Kenya and Middle East. B2B development team has developed HR & Payroll add-ons specific to different countries for Microsoft Dynamics Partners on NAV and AX.  Our expertise and understanding of Microsoft's suite of products combined with our industry knowledge and consulting experience enables us to quickly focus on selling and providing services related to Microsoft Dynamics Products Our relationship with Microsoft has contributed to our ability to expand and maintain our worldwide presence, enabled us to provide input on product enhancement and gain access to Microsoft resources that facilitate product placement and services opportunities in the market Risk and Risk Mitigations: Microsoft Dynamics being a growing business, new entrants into the market and competition will continue to exert pricing pressure undermining industry profitability, Strategic positioning and generating higher level of economic value by continuing to build IP and offer value added services around verticals and add-on's is mandatory. Scale of operations is limited to the existing level unless a fresh funding route is identified.




Crs.FY 12FY 13FY 14FY 15Q1 FY 16Q2 FY 16
Sales5.556.087.238.291.771.83
Net Profit-0.080.260.680.730.240.62
NPM4.28%9.41%8.81%13.56%33.88%















Promoter Holding 74.72%
Long Term Debt - Nil



Friday 9 October 2015

Kellton Tech Recommended at Rs 13.29 on 24th August 2014 touches Rs 119.25...heading towards 10 bagger.

Sunday 23 August 2015

Dhanlaxmi Fabrics

Dhanlaxmi Fabrics: CMP 34.50


  1. Increasing promoter holding
  2. Low equity base and 884 public shareholder holding 9.19% share (excluding 2 shareholders who own 16.37%).
  3. Increasing topline and decent margins.













https://www.screener.in/company/521151/consolidated/









This is not a stock recommendations for Buy or Sell.Please do your own research or consult financial adviser before taking investment decision. I am not a research analyst or Financial adviser.

Registration Status with SEBI: I am not registered with SEBI under SEBI (Research Analysts) Regulations, 2014. As per the clarifications provided by SEBI: “Any person who makes recommendation or offers an opinion concerning securities or public offers only through public media is not required to obtain registration as research analyst under RA Regulations”.

Monday 12 January 2015

ET Article - In 2015 Sensex looks relatively well placed

In 2015 Sensex looks relatively well placed
1 Jan, 2015, 07.20AM IST

By Saurabh Mukherjea, CEO - Institutional equities Ambit Capital

Neither GDP growth nor earnings growth has any meaningful relationship with the investment returns generated by the Sensex. Investment returns seem to be dependent on three very different sets of dynamics: (a) Reversion to the mean; (b) The political-economic cycle in India; and (c) The US monetary policy cycle. Seen against these three set of 'stories', the Sensex looks relatively well placed as we enter 2015. We reiterate our end-FY16 target of 36000 for the Sensex. 

So, if neither GDP growth nor EPS growth drives the stock market, what drives it? Secondly, are these drivers predictable at all? Over the last 30 years, there has been a pronounced tendency for the Sensex's returns to revert to the mean, with the mean being around 17%, marginally higher than the cost of equity in India (which is likely to be around 15%).

MEAN REVERSION

Why does mean reversion work so well as a predictor of Sensex returns over five-year cycles? The best answer we have heard is from the promoter of one of the largest road building companies in south India. The promoter told us last week that "when capital is cheap and abundantly available, the bidding for NHAI contracts is so intense that the returns from winning these road projects fallHowever, the more aggressive road building companies take on these contracts. Then over the next 4-5 years these aggressive bidders gradually slide into financial difficulties. As the financial backers of these bidders lose money, they get disenchanted with the sector and the availability of capital dries up. As capital becomes scarce, there are fewer and fewer bidders for the NHAI and state highway contracts. Then over the next 4-5 years these aggressive bidders gradually slide into financial difficulties. As the financial backers of these bidders lose money, they get disenchanted with the sector and the availability of capital dries up. As capital becomes scarce, there are fewer and fewer bidders for the NHAI and state highway contracts. As a result, the returns from taking these contracts rise. Gradually, that attracts more capital into the road building sector and another cycle begins." 

THE POLITICAL-ECONOMIC CYCLE

The Sensex seems to move in sync with India's political cycle. In particular, the Indian economy seems to move in 8-10-year economic cycles, with the beginning of these cycles coinciding with decisive general election results (eg 1984, 1991, and 2004). Then in the first three years of these economic cycles, the Sensex seems to appreciate sharply as investors discount the decade-long economic cycle. So, while the Sensex's 30-year CAGR is 16%, its CAGR during the first three years of each of the economic cycles (1984-87, 1991-94 and 2004-07) is about 33%.

In India, the power of the cycle to drive stock market returns is heightened by the fact that for as long as we can remember, the Indian middle class has been looking for a 'strong leader' who can compensate for the consistent weakness of the Indian state and give structure and shape to the country's aspirations. 

THE US INTEREST RATE CYCLE

Sensex returns seem to have a relatively tight relationship with turning points in the US monetary policy cycle. When US Government bond yields start rising in the wake of the Federal Reserve signalling a tightening of the US rate cycle, money flows out of the US bond market and into global equities. Emerging market equities and the Sensex benefit from this. Almost every period of rising bond yields in the US has been accompanied by a rally in the Sensex. 

What do these three sets of 'stories' portend for India? These stories seem to have the greatest impact on the Indian stock market when they interplay with each other fully. For example, in 2004, India was coming out of an economic slump with almost five consecutive years of negative returns for the Sensex (FY99: -4%; FY2000: 30%; FY01: -28%; FY02: -4%; FY03: -12%). As a result, the cost of capital was high and, hence, the available rates of return were juicy. The Sensex was due a reversion to the mean. The 2004 general election result, which gave the UPA an unexpected absolute majority in the Lok Sabha, brought to helm the PM-FM team of Manmohan Singh-Chidambaram, men who had reformist credentials and who investors were willing to back after the initial post-election hiccup. The Federal Reserve announced in 2004 that it was going to begin tightening the monetary policy. As a result, US bond yields started rising from 2004 onwards.

The three stories then combined to give five consecutive years of positive returns for the Sensex (FY04: 83%; FY05: 16%; FY06: 74%; FY07: 16%; FY08: 20%). 

In a similar vein, the three stories seem to be in the right place for India going into 2015. India is emerging from an economic slump with a spate of sub-par years for the Sensex (FY11: 11%; FY12: -10%; FY13: 8%; FY14: 19%; FY15 YTD: 22%).

The Federal Reserve has indicated by bringing QE to an end three months ago that at some stage in CY15, rates will start rising. Going forward, as the US denominated cost of funding rises and provided the cost of commodities stays muted, India stands to benefit.